Prot # MPI-101-06. Oral Budesonide Suspension (OBS) In Adolescent and Young Adult Subjects (12-25 Years Of Age) With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With An Open-Label Extension

Project: Research project

Project Details

StatusFinished
Effective start/end date9/13/12 → 9/13/15

Funding

  • SynteractHCR, Inc. (Prot # MPI-101-06)
  • Meritage Pharma, Inc (Prot # MPI-101-06)